A study found that lactulose improved cognitive function and health-related quality-of-life in patients with minimal hepatic encephalopathy, a condition associated with advanced liver disease. The treatment showed significant improvement in emotional behavior, movement, mobility, sleep/rest, and recreational activities.
A new study found that a series of simple blood tests can accurately diagnose liver fibrosis in patients with chronic hepatitis C. The FibroIndex was more accurate than two other indices and showed promise as a non-invasive alternative to liver biopsy.
Researchers have discovered a new way to fight colorectal cancer by targeting the 'skeletons' of cancer cells, which enable them to reproduce and spread. High-dose PPARgamma inhibitors destroy cancer cell microtubules, reducing their ability to grow and metastasize.
A new investigation into Napoleon's cause of death reveals that he died of a very advanced case of gastric cancer stemming from an ulcer-causing bacterial infection. The analysis suggests that gastrointestinal bleeding was the likely immediate cause of death and points to a poor prognosis for patients with such advanced cancer.
A new study found that 61% of chronic hepatitis C patients treated with Interferon developed asymptomatic retinopathy, including retinal hemorrhage and cotton-wool spots. The condition was associated with increased blood velocity and endothelial dysfunction, highlighting the importance of monitoring patients during treatment.
A recent double-blind study found that long-acting octreotide did not improve outcomes for patients with liver cancer compared to a placebo. The study enrolled 119 patients and followed them for over 30 months, but showed no significant difference in survival rates between the two groups.
Researchers found that African-American patients had a lower risk of hepatic steatosis compared to Caucasian patients, despite similar prevalence rates. Insulin resistance was identified as an important factor in predicting treatment response.
Researchers have developed a gene chip that can detect genetic causes of jaundice in children and adults, potentially leading to personalized treatment options. The 'jaundice chip' is nearly 100% effective in detecting common mutations associated with inherited liver diseases.
A study published in Clinical Gastroenterology and Hepatology found that stool DNA testing can detect colorectal cancer with 88% accuracy, regardless of its stage or location. This non-invasive screening test offers a patient-friendly alternative to traditional colonoscopy.
Research on mice carrying a mutated human gene for alpha-1-antitrypsin deficiency found that a non-steroidal anti-inflammatory drug significantly increased liver damage. The study suggests that NSAIDs could exacerbate liver injury in people with alpha-1-AT deficiency, highlighting the need to avoid these drugs.
A new study found that individuals who had tested positive for hepatitis C but later tested negative were significantly less likely to become infected again compared to those who had never been infected. This suggests that previous exposure to HCV may be protective against reinfection, possibly on an immunologic basis.
Researchers discovered that liver cells can activate T cells independently of the lymph system, potentially contributing to impaired immune responses in chronic hepatitis C. The study found that T cells interact with liver cells through fenestrations in sinusoidal endothelial cells.
A new study by Saint Louis University researchers shows a cocktail of ribavirin and Infergen is nearly twice as effective in controlling hepatitis C than standard treatments. Fourteen percent of patients taking the treatment were virus-negative after six months.
The AGA Institute's report emphasizes the need for gastroenterologists to adapt to changing practices, technologies, and economic pressures. Key findings include the potential obsolescence of common endoscopic procedures due to technological advancements and increased utilization of nurse practitioners and physician assistants.
Researchers at the Mayo Clinic have developed a novel method to digitally capture and analyze colonoscopy video files, extracting objective quality metrics. The study also found adalimumab effective in inducing remission in patients with moderate to severe Crohn's disease.
A study found that patients with NAFLD have a significant risk of developing end-stage liver disease, cardiovascular complications, and diabetes. Lifestyle modifications are recommended to reduce the risk of type 2 diabetes and improve liver histology.
A study found that higher levels of specialized blood cells from bone marrow are associated with liver cancer prognosis. Elevated endothelial progenitor cells were linked to poorer outcomes in patients with inoperable hepatocellular carcinoma.
Healthcare providers must weigh benefits and risks of NSAID use, which are associated with gastrointestinal complications. The AGA Institute recommends lower-risk agents and gastroprotection methods for patients at high risk of GI complications.
The partnership aims to support the training of young investigators in pediatric gastroenterology, hepatology, and nutrition. Hepatology will now be made available without charge to NASPGHAN fellows.
A study on liver transplant patients found that those with low bone density before transplant showed significant improvement afterwards. Bone loss immediately following transplant was common and several risk factors were identified, including PSC, younger age at transplant, and smoking.
A Hopkins study shows that combining curcumin and quercetin greatly reduces the size and number of colorectal polyps in patients with familial adenomatous polyposis. The average number of polyps dropped 60.4 percent, and the average size dropped by 50.9 percent.
Researchers at Thomas Jefferson University found that blocking Rho kinase activity could be a viable treatment for gastrointestinal disorders such as constipation, anal fissures, and hemorrhoids. The study showed that Rho kinase inhibitors can cause direct smooth muscle relaxation and may provide a new strategy to treat these conditions.
A simple blood test can indicate the presence of non-alcoholic steatohepatitis by measuring caspase 3-generated cytokeratin-18 fragments. This test has shown high sensitivity and specificity in differentiating NASH from non-NASH in patients with suspected NAFLD.
A study found that a combination of pegylated interferon and ribavirin achieved better results than standard therapy in patients with recurrent hepatitis C after liver transplantation. The treatment was more effective, especially when patients showed an early decline in viral load.
Researchers discovered statins inhibit HCV replication without killing host cells. Fluvastatin showed strongest effect in combination with interferon, leading to effective HCV RNA replication inhibition.
According to a study published in The Lancet, heartburn is more common in Western populations compared to non-Western populations. Lifestyle factors such as obesity and smoking contribute to the development of gastro-oesophageal reflux disease (GORD), which can lead to significant economic burdens.
The authors of a commentary propose developing educational messages about genetic testing to address misunderstandings and societal fears. This could involve collaboration between professional organizations, patient advocacy groups, and the public at large to improve the interpretation of test results.
Obesity disrupts hormone signaling pathways and leads to metabolic changes that worsen liver disease. Researchers recommend weight loss, insulin-sensitizing drugs, or increased dosages of combination therapy to improve treatment outcomes for hepatitis C patients.
Recent studies demonstrate improved virus suppression with novel therapy combinations for hepatitis treatment, including valopicitabine plus peg-interferon. Researchers found a higher dose of the drug showed promising results, but also led to side effects that forced dosage reduction.
Researchers found patients with NAFLD had an increased risk of heart disease, particularly among women. Elevated ALT activity in the absence of viral hepatitis or excessive alcohol consumption is most commonly due to NAFLD and associated with an increased risk of coronary heart disease.
This study found that pediatric liver transplant patients develop chronic hepatitis, characterized by increasing fibrosis and autoantibody production. Regular monitoring of autoantibodies is necessary for early detection.
Liver injuries continue to plague the nation's drug development system, causing costly problems for pharmaceutical companies. Dr. Navarro proposes that patients speak with their physicians about their medications to detect liver injury early, as certain individuals are more likely to develop problems due to genetic makeup.
COX-2 inhibitors and other NSAIDs can provide pain relief for patients with dormant inflammatory bowel disease without increasing the risk of flare-ups. Studies show that these medications are tolerated well by IBD patients, despite minimal risks, and can be a safe option for pain management.
A randomized controlled study found that pretreating patients with hepatocellular carcinoma (HCC) undergoing chemotherapy with lamivudine significantly reduces the risk of Hepatitis B reactivation and severe hepatitis. The study identified a lower viral load threshold as a better predictor of relapse.
Researchers found that 56% of older HCV patients experienced dose reductions or discontinuations due to adverse effects, negatively impacting sustained virological response rates. The study emphasizes the need for modified treatment schedules and patient education to improve outcomes for this vulnerable population.
Researchers found that cholestasis is associated with a broad activation of immune cells producing TNF-alpha, leading to behavioral changes and alterations in neurotransmitter systems. The study provides a novel mechanism linking liver disease to CNS sickness behavior, potentially informing the development of therapeutic agents.
A new study by Regino González-Peralta and colleagues found that interferon in combination with ribavirin is an effective treatment for childhood chronic hepatitis C, with sustained virologic response rates higher than those using interferon alone. Common side effects were mild, but severe adverse events occurred in some children.
A new laboratory test has been developed to identify patients at high risk of developing cirrhosis after a liver transplant due to hepatitis C. The test targets hepatic stellate cells, which can produce collagen leading to scarring in infected patients.
A new study finds that co-therapy with erythropoietin is more cost-effective than standard treatment for patients with Hepatitis C and treatment-induced anemia. The research suggests that this treatment approach can improve rates of complete cure from the disease, making it a viable option for this patient population.
Researchers identified alpha-smooth muscle actin (alpha-SMA) as a reliable marker for predicting fibrosis development after liver transplant. Studies showed that HSC activation was associated with advanced fibrosis, suggesting a potential biomarker for early intervention and treatment.
The pediatric acute liver study, directed from Children's, will investigate the causes and treatment of acute liver failure in children. The three aspects of the study include developing a registry, therapeutic clinical trials, and basic research into genetic causes of the condition.
A recent study published by the American Gastroenterological Association found that nearly 80% of Asian patients with chronic HCV developed cirrhosis after 60 years of infection. The study's results confirm that fibrosis progression is the same across ethnic groups, leading to cirrhosis and liver disease at a similar rate in everyone.
Research suggests that high blood lactate levels can accurately predict a poor outcome in patients with fulminant hepatic failure (FHF). The study examined the relationship between serum phosphate and lactate levels in FHF patients, finding that lactate levels were significantly higher in those who died or underwent a transplant.
A study found a strong relationship between HCV infection and having an anti-HCV positive family member, with the highest incidence rate in children under 10 living in households with an anti-HCV positive parent. Parenteral exposures increased the risk of HCV, particularly in men married to an HCV positive woman.
A study of 1,193 patients found only 94 received the HAV vaccine, highlighting a significant gap in vaccination rates. Patients with chronic HCV were at risk for severe liver disease and death if infected with HAV, emphasizing the need for increased awareness and vaccination efforts.
Researchers found that alendronate, combined with calcium and vitamin D, significantly prevented further bone loss in liver transplant patients for four months after the procedure. After three years, patients with osteopenia or osteoporosis showed improved BMD despite not reaching normal levels.
A study analyzing reports of suspected drug-induced liver injury found that AST and bilirubin levels are key predictors of death or liver transplant in patients with severe drug-induced liver disease. Patients with hepatocellular liver damage had a higher mortality rate, highlighting the importance of monitoring these biomarkers.
Researchers found that asymptomatic autoimmune hepatitis patients had lower liver enzyme and IgG antibody levels, but did not differ from symptomatic patients in terms of inflammation. Despite treatment recommendations, most asymptomatic patients do well without immunosuppressive therapy as long as they remain asymptomatic.
A study published in Hepatology found that severe sleep apnea is a risk factor for liver damage, independent of body mass index. Patients with severe sleep apnea had higher levels of insulin resistance and fatty liver disease, suggesting a link between obstructive sleep apnea and the development of nonalcoholic steatohepatitis.
A randomized, double-blind placebo-controlled crossover trial found that ondansetron did not have a fatigue-reduction benefit greater than the considerable placebo effect. The study suggests that other drugs targeting the central nervous system may prove effective in combating fatigue associated with primary biliary cirrhosis.
Researchers found that rifaximin significantly improved disease activity in patients with Crohn's disease. The analysis of 8 patients showed a mean decrease in Harvey Bradshaw index of 7.1, indicating potential effectiveness as a treatment.
In two studies, Lichtenstein and colleagues found that Rifaximin relieved symptoms of SBBO and pouchitis in patients with Crohn's disease, scleroderma, and mixed connective tissue disorders. The antibiotic demonstrated complete remission of symptoms in most patients, with no adverse events reported.
Researchers found statin chemoprevention to be a promising strategy for managing patients with chronic ulcerative colitis, preventing 90-96% of colon cancers. Compared to frequent colonoscopic surveillance, this approach may improve quality of life and reduce costs.
A study of 54 patients with ALD who underwent liver transplants found that those who resumed alcohol consumption had significantly lower 10-year survival rates compared to abstinent patients. Higher mortality rates among relapse group were attributed to increased risk of cancers and cardiovascular events.
Researchers found that overweight patients, those with moderate income, and women survived longer with esophageal and stomach cancer. Premature birth significantly increases the risk of esophageal adenocarcinoma, potentially linked to gastroesophageal reflux disease.
Researchers at U-M Health System found that disease severity in patients with ulcerative colitis can be accurately evaluated without frequent lower endoscopies. The study suggests using non-invasive indices, such as patient-reported symptoms, to monitor disease activity and spare patients the discomfort of regular endoscopies.
A new study reveals that liver disease can impair learning ability by disrupting the glutamate-nitric oxide-cGMP pathway in the brain. Sildenafil treatment restored learning ability in rats with portacaval shunts and those with hyperammonemia, suggesting a potential therapeutic approach for patients with hepatic encephalopathy.
The American Gastroenterological Association recommends colonoscopy as the preferred screening method for colorectal cancer due to its ability to detect and remove precancerous polyps. In-office fecal occult blood tests are not recommended as a standalone screening test, but can be used in conjunction with flexible sigmoidoscopy.
Pegylated interferon-alpha shows promise in treating chronic hepatitis B infection, with higher sustained viral response rates compared to monotherapy. The study highlights the importance of hepatitis B virus genotype as a predictor of treatment response.
A recent study published in Hepatology found that occult HBV infection is prevalent in adult hemodialysis patients, with a rate four to five times higher than standard HBsAg testing. The majority of infections were associated with low viral loads and the sG145R-mutant.